Cancer continues to be one of the fastest-growing and most unpredictable drivers of healthcare spend today. But the biggest opportunity to better manage that spend isn't just reducing costs, it's ensuring care is delivered correctly from the start. In this session, we reframe how benefits leaders think about cancer spend by focusing on the role of evidence-based care in shaping total cost of care.

You'll learn:
- Why cancer care varies more than most employers realize and how that impacts cost
- How gaps in diagnostics, testing, and treatment decisions drive downstream spend
- Why access to subspecialty expertise changes clinical and financial outcomes
- What a population-wide approach to cancer management looks like in practice and its impact on ROI

This session is hosted by the From Day One editorial team, with support from AccessHope.

From Day One is a Recertification Provider for SHRM and HRCI. This session is eligible for 1 credit from both organizations. The Activity IDs will be sent to attendees after the conclusion of the session.